← Back to headlines




Takeda Partners with Insilico Medicine for AI Drug Discovery
Takeda has made a new investment in AI-driven drug discovery by partnering with Insilico Medicine, aiming to leverage artificial intelligence for pharmaceutical innovation.
5 Jul, 17:31 — 5 Jul, 17:31
Sources
Showing 1 of 1 sources
Related Stories

LIV Golf Files for Chapter 11 Bankruptcy Protection Amid Financial Uncertainty
24m ago

Meta Launches Muse, a Personal AI Agent for Emails and Payments
38m ago

Canada Implements Retaliatory Tariffs Against US and Pivots Economy
39m ago

Trump Moves to Exclude Canadian Products from US Government Contracts
56m ago